TY  - GEN
AU  - Albouy,B
AU  - Gross Goupil,M
AU  - Escudier,B
AU  - Massard,C
TI  - [Renal cell carcinoma management and therapies in 2010]
SN  - 1769-6917
PY  - 2010///0519
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Benzenesulfonates
KW  - Bevacizumab
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Combined Modality Therapy
KW  - Everolimus
KW  - Humans
KW  - Indoles
KW  - Interferons
KW  - Interleukin-2
KW  - Intracellular Signaling Peptides and Proteins
KW  - antagonists & inhibitors
KW  - Kidney Neoplasms
KW  - Metabolic Networks and Pathways
KW  - drug effects
KW  - Nephrectomy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Serine-Threonine Kinases
KW  - Pyridines
KW  - Pyrroles
KW  - Sirolimus
KW  - Sorafenib
KW  - Sunitinib
KW  - TOR Serine-Threonine Kinases
KW  - Vascular Endothelial Growth Factor A
KW  - metabolism
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1684/bdc.2010.1067
ER  -